Slaughter and May advised Lonza Group AG ("Lonza") on an issuance under its €8,000,000,000 Euro Medium-Term Note Programme (the "Programme"). Lonza Finance International NV issued €600,000,000 3.250 per cent. Fixed Rates Notes due 2030 and €600,000,000 3.500 per cent. Fixed Rates Notes due 2034 under the Programme. The Notes are guaranteed by Lonza and are listed on the Luxembourg Stock Exchange.
This marks Lonza's third and fourth drawdown under the Programme established in 2023. The proceeds will be used for general corporate purposes, including the financing of acquisitions and refinancing of debt.
Founded in 1897 in the Swiss Alps, today, Lonza is one of the world's largest healthcare manufacturing organisations, helping pharmaceutical, biotech and nutrition companies to bring their treatments to market.
Slaughter and May worked closely with Lonza's legal and treasury teams, and were supported by Advestra AG who acted as legal advisors in Switzerland and A&O Shearmen who acted as legal advisors in Belgium.
